Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of panretinal photocoagulation plus
intravitreal ranibizumab for the treatment of patients with high risk proliferative diabetic
retinopathy in terms of changes in visual acuity and neovascularization area.